SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-13
👔
PTC THERAPEUTICS, INC.
@PTCT_InsiderForm 4 Filing: Smith Mary L. Sells $2.1M of $PTCT
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
PTC THERAPEUTICS, INC.
Ticker: $PTCT
Transaction Value
$2.1M
Price/Share: $66.47
transaction date
2026-07-09
Shares: 31,668
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Smith Mary L., holds the title of Director at PTC THERAPEUTICS, INC..
On 2026-07-09, the insider transacted 31,668 shares.The shares were transacted at a weighted average price of $66.47 per share, resulting in a total market-relevant value of $2.1M.
Executive Summary Summary
Smith Mary L. (Director) sold $2.1M of $PTCT
Post-Transaction Position: 21,813 shares
SEC Accession No: 0001866044-26-000005 (CIK: 1866044)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.